Journal article
Longitudinal treatment patterns with ADP receptor inhibitors after myocardial infarction: Insights from the Canadian Observational AntiPlatelet sTudy
Abstract
BACKGROUND: After myocardial infarction (MI) treated with percutaneous coronary intervention (PCI), guidelines recommend dual antiplatelet therapy (DAPT) with aspirin and an ADP receptor inhibitor (ADPri) for at least 1year. However, whether real-world Canadian practice patterns reflect this recommendation is unknown.
METHODS: We studied 2175 MI patients treated with PCI and discharged from 26 Canadian hospitals between 12/2011 and 05/2013 in …
Authors
Bagai A; Wang TY; Goodman SG; Fisher HN; Welsh RC; Dery J-P; Zhang X; Zhu YE; Cheema AN; Dehghani P
Journal
International Journal of Cardiology, Vol. 228, , pp. 459–464
Publisher
Elsevier
Publication Date
February 2017
DOI
10.1016/j.ijcard.2016.11.240
ISSN
0167-5273
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdenosineAgedCanadaClopidogrelDose-Response Relationship, DrugDrug Therapy, CombinationFemaleFollow-Up StudiesHumansMaleMiddle AgedMyocardial InfarctionPercutaneous Coronary InterventionPlatelet Aggregation InhibitorsPrasugrel HydrochloridePurinergic P2 Receptor AntagonistsRetrospective StudiesTicagrelorTiclopidineTreatment Outcome